Healthcare provider profile · identity verified

Deborah Esteves, M.D.

Internal Medicine · PORTAGE, MI · NPI 1073603791

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	448	145
Amlodipine Besylate	Amlodipine Besylate	409	119
Levothyroxine Sodium	Levothyroxine Sodium	285	75
Losartan Potassium	Losartan Potassium	210	66
Lisinopril	Lisinopril	180	51
Famotidine	Famotidine	132	55
Albuterol Sulfate Hfa	Albuterol Sulfate	125	62
Atenolol	Atenolol	121	35
Gabapentin	Gabapentin	97	34
Meloxicam	Meloxicam	91	20
Hydrochlorothiazide	Hydrochlorothiazide	90	24
Pantoprazole Sodium	Pantoprazole Sodium	88	30
Tamsulosin Hcl	Tamsulosin Hcl	84	24
Metformin Hcl	Metformin Hcl	80	25
Ibuprofen	Ibuprofen	76	26
Alendronate Sodium	Alendronate Sodium	69	24
Metoprolol Tartrate	Metoprolol Tartrate	62	21
Metformin Hcl Er	Metformin Hcl	60	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	17
Trazodone Hcl	Trazodone Hcl	59	21
Wixela Inhub	Fluticasone Propion/Salmeterol	58	26
Furosemide	Furosemide	52	13
Allopurinol	Allopurinol	51	17
Lovastatin	Lovastatin	51	16
Simvastatin	Simvastatin	51	15
Sertraline Hcl	Sertraline Hcl	49	16
Montelukast Sodium	Montelukast Sodium	48	14
Fluticasone Propionate	Fluticasone Propionate	47	17
Fluoxetine Hcl	Fluoxetine Hcl	45	17
Metoprolol Succinate	Metoprolol Succinate	42	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	13
Mirtazapine	Mirtazapine	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Glipizide	Glipizide	36	14
Terazosin Hcl	Terazosin Hcl	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	30	13
Finasteride	Finasteride	30	suppressed
Alvesco	Ciclesonide	28	14
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Omeprazole	Omeprazole	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Rosuvastatin Calcium	Rosuvastatin Calcium	19	suppressed
Cefadroxil	Cefadroxil	18	15
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Nystatin	Nystatin	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Prednisone	Prednisone	16	15
Baclofen	Baclofen	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Diazepam	Diazepam	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Jardiance	Empagliflozin	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Fluocinolone Acetonide	Fluocinolone/Shower Cap	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error